| Literature DB >> 24999730 |
Marion Girod1, Quentin Enjalbert2, Claire Brunet2, Rodolphe Antoine2, Jérôme Lemoine1, Iva Lukac3, Miroslav Radman4, Anita Krisko5, Philippe Dugourd2.
Abstract
Accumulation of oxidative damage in proteins correlates with aging since it can cause irreversible and progressive degeneration of almost all cellular functions. Apparently, native protein structures have evolved intrinsic resistance to oxidation since perfectly folded proteins are, by large most robust. Here we explore the structural basis of protein resistance to radiation-induced oxidation using chicken egg white lysozyme in the native and misfolded form. We study the differential resistance to oxidative damage of six different parts of native and misfolded lysozyme by a targeted tandem/mass spectrometry approach of its tryptic fragments. The decay of the amount of each lysozyme fragment with increasing radiation dose is found to be a two steps process, characterized by a double exponential evolution of their amounts: the first one can be largely attributed to oxidation of specific amino acids, while the second one corresponds to further degradation of the protein. By correlating these results to the structural parameters computed from molecular dynamics (MD) simulations, we find the protein parts with increased root-mean-square deviation (RMSD) to be more susceptible to modifications. In addition, involvement of amino acid side-chains in hydrogen bonds has a protective effect against oxidation Increased exposure to solvent of individual amino acid side chains correlates with high susceptibility to oxidative and other modifications like side chain fragmentation. Generally, while none of the structural parameters alone can account for the fate of peptides during radiation, together they provide an insight into the relationship between protein structure and susceptibility to oxidation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24999730 PMCID: PMC4085010 DOI: 10.1371/journal.pone.0101642
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Workflow of the analytical method.
Summary of the data for observed peptides analyzed by SRM.
| Peptide (and position in the protein sequence) | Transitions (Q1/Q3) | Fragment ion |
|
| 447.21/491.26 | (y5)+ |
| 447.21/604.35 | (y6)+ | |
| 447.21/290.08 | (b2)+ | |
|
| 437.71/680.34 | (y5)+ |
| 437.71/737.36 | (y6)+ | |
| 437.71/195.09 | (b2)+ | |
|
| 663.32/905.43 | (y8)+ |
| 663.32/1105.55 | (y10)+ | |
| 663.32/221.09 | (b2)+ | |
|
| 714.83/951.46 | (y8)+ |
| 714.83/1152.54 | (y10)+ | |
| 714.83/277.12 | (b2)+ | |
|
| 497.20/232.14 | (y2)+ |
| 497.20/621.24 | (y5)+ | |
| 497.20/807.32 | (y6)+ | |
|
| 523.27/673.38 | (y5)+ |
| 523.27/887.47 | (y7)+ | |
| 523.27/159.08 | (b2)+ | |
|
| 455.21/507.26 | (y5)+ |
| 455.21/620.34 | (y6)+ | |
| 455.21/290.08 | (b2)+ | |
|
| 531.27/689.37 | (y5)+ |
| 531.27/788.44 | (y6)+ | |
| 531.27/159.08 | (b2)+ | |
|
| Not followed in SRM | - |
|
| Not followed in SRM | - |
Figure 2Analysis of the reduced-alkylated lysozyme irradiated with a dose at 1000 Gy.
(a) TIC chromatogram, (b) CID spectrum of the CELAAAMK ion m/z 447.2 detected between 8.8 and 9.9 min and (c) CID spectrum of the CELAAAK ion m/z 455.2 detected between 6.8 and 7.2 min.
Figure 3Evolution of the signal of the CELAAAMK peptide (a, b) and oxidized CELAAAK peptide (c, d).
CELAAAMK peptide (3 transitions) irradiated in the native (a) and reduced-alkylated form (b) Oxidized CELAAAK peptide (3 transitions) irradiated in the native (c) and reduced-alkylated form (d).
Characteristic doses t1 and t2 for observed peptides from native and reduced-alkylated form of lysozyme.
| Peptide | From Native irradiated Lysozyme | From Reduced-alkylated irradiated Lysozyme | ||||||
| t1 (Gy) | CV (%, | t2 (Gy) | CV (%, | t1 (Gy) | CV (%, | t2 (Gy) | CV (%, | |
| CELAAAMK | 7.9 | 9 | 445.7 | 10 | 44.5 | 19 | 670.2 | 12 |
| CELAAA | 25.1 | 18 | 485.2 | 17 | 75.8 | 9 | 641.1 | 6 |
| GTDVQAWIR | 58.9 | 14 | 338.9 | 15 | 21.1 | 14 | 570.3 | 10 |
| GTDVQA | 82.4 | 10 | 675.2 | 8 | 38.9 | 16 | 651.6 | 15 |
| HGLDNYR | 50.2 | 4 | 375.2 | 6 | 18.5 | 17 | 386.7 | 19 |
| GYSLGNWVCAAK | 88.8 | 13 | 279.2 | 14 | 17.3 | 6 | 346.3 | 4 |
| FESNFNTQATNR | 19.4 | 7 | 549.1 | 9 | 11.5 | 6 | 502.6 | 9 |
| WWCNDGR | 75.4 | 15 | 654.2 | 12 | 33.8 | 12 | 678.6 | 8 |
CV stands for coefficient of variation.
Half-life irradiation doses (D50) and saturating intensity (Isat) measured for each observed peptide from native and reduced-alkylated form of lysozyme.
| Peptide | From Native irradiated Lysozyme | From Reduced-alkylated irradiated Lysozyme | ||||||
| D50 (Gy) | CV (%, | Isat (%) | CV (%, | D50 (Gy) | CV (%, | Isat (%) | CV (%, | |
| CELAAAMK | 10 | 12 | 7.5 | 7 | 1241 | 18 | 42 | 12 |
| GTDVQAWIR | 385 | 11 | 28.6 | 12 | 26 | 9 | 11 | 11 |
| HGLDNYR | 50 | 7 | 9.1 | 8 | 100 | 8 | 12.5 | 8 |
| GYSLGNWVCAAK | 150 | 8 | 13.2 | 7 | 298 | 16 | 32.1 | 10 |
| FESNFNTQATNR | 30 | 12 | 8.4 | 10 | 10 | 10 | 7.1 | 11 |
| WWCNDGR | 510 | 18 | 32.6 | 9 | 130 | 8 | 27.9 | 12 |
CV stands for coefficient of variation.
Figure 4Lysozyme tertiary structure (PDB:1AKI).
(a) CELAAAMK is shown in yellow, GTDVQAWIR in green, HGLDNYR in white, GYSLGNWVCAAK in blue, FESNFNTQATNR in pink and WWCNDGR in red. (b) 180° degree rotation around y-axis.
Figure 5Sequence of the chicken lysozyme with, highlighted in blue, the detected peptides.
Summary of backbone and side-chain root mean square deviation (RMSD) data for each observed peptide from the native and reduced-alkylated lysozyme.
| Average RMSD Å | ||||||||
| Native, run 1 | Native, run 2 | Reduced-alkylated, run 1 | Reduced-alkylated, run 2 | |||||
| Backbone | Side-chain | Backbone | Side-chain | Backbone | Side-chain | Backbone | Side-chain | |
| CELAAAMK | 0.79 | 1.25 | 0.83 | 1.22 | 0.78 | 1.37 | 1.06 | 1.47 |
| GTDVQAWIR | 1.03 | 1.65 | 1.21 | 1.56 | 1.42 | 1.94 | 1.44 | 1.9 |
| HGLDNYR | 1.03 | 1.94 | 1.02 | 2.01 | 1.14 | 1.98 | 1.2 | 2.02 |
| GYSLGNWVCAAK | 0.66 | 0.81 | 0.83 | 1.11 | 0.94 | 1.21 | 0.87 | 1.15 |
| FESNFNTQATNR | 0.77 | 1.11 | 1.22 | 2.64 | 0.93 | 1.6 | 0.87 | 1.73 |
| WWCNDGR | 0.74 | 1.3 | 0.92 | 1.53 | 1.34 | 2.63 | 1.31 | 2.24 |
The results of the two molecular simulation runs are presented separately.
Average number of occupied hydrogen bonds in % (total and side-chain—side-chain) for each observed peptide from the native and reduced-alkylated lysozyme.
| Hydrogen bonds | ||||||||
| Native, run 1 | Native, run 2 | Reduced-alkylated, run 1 | Reduced-alkylated, run 2 | |||||
| Total | Side-chain | Total | Side-chain | Total | Side-chain | Total | Side-chain | |
| CELAAAMK | 588 | 120 | 614 | 114 | 530 | 98 | 546 | 106 |
| GTDVQAWIR | 202 | 14 | 193 | 7 | 165 | 3 | 212 | 1.6 |
| HGLDNYR | 562 | 88 | 563 | 74 | 573 | 93 | 544 | 55 |
| GYSLGNWVCAAK | 758 | 145 | 529 | 124 | 590 | 33 | 531 | 33 |
| FESNFNTQATNR | 640 | 44 | 860 | 75 | 1142 | 122 | 923 | 83 |
| WWCNDGR | 833 | 299 | 891 | 205 | 777 | 208 | 847 | 322 |
The results of the two molecular simulation runs are presented separately.
Summary of root mean square deviation (rmsd) and solvent accessible surface area (SASA) for Trp 62, Trp63 and Trp123 residues from the native and reduced-alkylated lysozyme.
| Trp62 ( | |||||
| RMSD | SASA (nm2) | ||||
| hydrophobic | hydrophilic | total | ÄGsolv (kJ/mol) | ||
| Native, run 1 | 1.26 | 0.93 | 0.13 | 1.05 | −2.65 |
| Native, run 2 | 0.96 | 0.97 | 0.13 | 1.10 | −2.77 |
| Reduced-alkylated, run 1 | 1.07 | 1.07 | 0.12 | 1.20 | −3.00 |
| Reduced-alkylated, run 2 | 1.09 | 1.09 | 0.13 | 1.22 | −3.06 |
| Trp63 (W | |||||
| RMSD | SASA (nm2) | ||||
| hydrophobic | hydrophilic | total | ÄGsolv (kJ/mol) | ||
| Native, run 1 | 0.64 | 0.35 | 0.09 | 0.44 | −1.11 |
| Native, run 2 | 0.74 | 0.30 | 0.10 | 0.40 | −1.01 |
| Reduced-alkylated, run 1 | 1.41 | 0.45 | 0.11 | 0.57 | −1.42 |
| Reduced-alkylated, run 2 | 1.53 | 0.38 | 0.09 | 0.47 | −1.17 |
| Trp123 (GTDVQA | |||||
| RMSD | SASA (nm2) | ||||
| hydrophobic | hydrophilic | total | ÄGsolv (kJ/mol) | ||
| Native, run 1 | 1.06 | 0.52 | 0.13 | 0.65 | −1.64 |
| Native, run 2 | 1.21 | 0.47 | 0.11 | 0.58 | −1.47 |
| Reduced-alkylated, run 1 | 1.4 | 0.47 | 0.13 | 0.60 | −1.52 |
| Reduced-alkylated, run 2 | 1.92 | 0.58 | 0.10 | 0.68 | −1.72 |
The results of the two molecular simulation runs are presented separately.